Pacer Advisors, Inc. Bio Techne Corp Transaction History

Pacer Advisors, Inc.

  • $35.5 Billion
  • Q1 2025

A detailed history of Pacer Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 8,120 shares of TECH stock, worth $417,368. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,120
Previous 12,755 36.34%
Holding current value
$417,368
Previous $918,000 48.15%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025
SELL
$58.47 - $78.75 $271,008 - $365,006
-4,635 Reduced 36.34%
8,120 $476,000
Q4 2024

Jan 22, 2025
SELL
$66.37 - $78.17 $196,256 - $231,148
-2,957 Reduced 18.82%
12,755 $918,000
Q3 2024

Nov 12, 2024
BUY
$70.96 - $82.35 $40,589 - $47,104
572 Added 3.78%
15,712 $1.26 Million
Q2 2024

Aug 13, 2024
BUY
$62.12 - $84.15 $278,794 - $377,665
4,488 Added 42.13%
15,140 $1.08 Million
Q1 2024

May 10, 2024
SELL
$65.98 - $77.09 $108,537 - $126,813
-1,645 Reduced 13.38%
10,652 $749,000
Q4 2023

Jan 16, 2024
SELL
$52.83 - $78.22 $597,084 - $884,042
-11,302 Reduced 47.89%
12,297 $948,000
Q3 2023

Nov 13, 2023
BUY
$67.52 - $89.42 $391,953 - $519,083
5,805 Added 32.62%
23,599 $1.61 Million
Q2 2023

Jul 12, 2023
BUY
$73.76 - $85.98 $413,498 - $482,003
5,606 Added 46.0%
17,794 $1.45 Million
Q1 2023

May 02, 2023
BUY
$71.62 - $86.62 $826,136 - $999,161
11,535 Added 1766.46%
12,188 $904,000
Q4 2022

Feb 06, 2023
SELL
$80.67 - $352.29 $92,044 - $401,962
-1,141 Reduced 63.6%
653 $54,000
Q3 2022

Oct 18, 2022
SELL
$282.54 - $391.85 $5,933 - $8,228
-21 Reduced 1.16%
1,794 $509,000
Q2 2022

Aug 12, 2022
SELL
$322.67 - $449.65 $4.86 Million - $6.77 Million
-15,048 Reduced 89.24%
1,815 $629,000
Q1 2022

Apr 05, 2022
BUY
$353.85 - $487.79 $2.85 Million - $3.93 Million
8,060 Added 91.56%
16,863 $7.3 Million
Q4 2021

Feb 03, 2022
BUY
$456.15 - $525.06 $2.81 Million - $3.24 Million
6,169 Added 234.21%
8,803 $4.55 Million
Q3 2021

Oct 15, 2021
SELL
$444.87 - $538.88 $649,955 - $787,303
-1,461 Reduced 35.68%
2,634 $1.28 Million
Q2 2021

Jul 21, 2021
SELL
$387.35 - $450.26 $18,592 - $21,612
-48 Reduced 1.16%
4,095 $1.84 Million
Q1 2021

Apr 05, 2021
BUY
$314.62 - $411.0 $46,249 - $60,417
147 Added 3.68%
4,143 $1.58 Million
Q4 2020

Jan 20, 2021
SELL
$246.9 - $321.87 $1.21 Million - $1.57 Million
-4,893 Reduced 55.05%
3,996 $1.27 Million
Q3 2020

Oct 19, 2020
BUY
$232.22 - $282.96 $2.06 Million - $2.52 Million
8,889 New
8,889 $2.2 Million
Q1 2020

Apr 23, 2020
SELL
$161.17 - $221.51 $2.09 Million - $2.87 Million
-12,960 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$189.68 - $222.09 $188,162 - $220,313
-992 Reduced 7.11%
12,960 $2.85 Million
Q3 2019

Oct 10, 2019
SELL
$183.56 - $216.72 $198,244 - $234,057
-1,080 Reduced 7.18%
13,952 $2.73 Million
Q2 2019

Aug 12, 2019
BUY
$188.72 - $215.43 $2.84 Million - $3.24 Million
15,032 New
15,032 $3.13 Million
Q4 2018

Feb 13, 2019
SELL
$132.75 - $203.8 $1.81 Million - $2.78 Million
-13,658 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$147.44 - $204.11 $261,558 - $362,091
1,774 Added 14.93%
13,658 $2.79 Million
Q2 2018

Aug 14, 2018
BUY
$144.9 - $165.58 $248,068 - $283,472
1,712 Added 16.83%
11,884 $1.76 Million
Q1 2018

May 14, 2018
BUY
$131.46 - $151.04 $150,916 - $173,393
1,148 Added 12.72%
10,172 $1.54 Million
Q4 2017

Feb 14, 2018
BUY
$121.17 - $134.75 $506,248 - $562,985
4,178 Added 86.22%
9,024 $1.17 Million
Q3 2017

Nov 08, 2017
BUY
$113.59 - $123.78 $550,457 - $599,837
4,846
4,846 $586,000

Others Institutions Holding TECH

# of Institutions
627
Shares Held
160M
Call Options Held
90K
Put Options Held
14.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.02B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email